Market closed· · SEK · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Sedana Medical AB (OSTO:SEDANA) advances towards US market entry amid mixed sales performance and financial adjustments.
Sedana Medical AB (OSTO:SEDANA) reports a positive EBITDA and stable gross margin amidst sales challenges, while advancing its US market entry.
Sedana Medical AB (OSTO:SEDANA) achieves record sales growth and makes significant strides in US market entry, despite challenges in European markets.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.